Your browser doesn't support javascript.
loading
Anti-CD3 monoclonal antibody treatment in newly diagnosed Type 1 diabetes patients: a hypothetical modelling analysis.
Smith-Palmer, J; Curtis, B H; Boye, K S; Goodall, G; Pillemer, S R.
Affiliation
  • Smith-Palmer J; IMS Health, Allschwil, Switzerland. jsmith-palmer@ch.imshealth.com
Diabet Med ; 27(2): 189-96, 2010 Feb.
Article in En | MEDLINE | ID: mdl-20546263
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD3 Complex / Diabetes Mellitus, Type 1 / Antibodies, Monoclonal Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Female / Humans / Male Language: En Journal: Diabet Med Journal subject: ENDOCRINOLOGIA Year: 2010 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD3 Complex / Diabetes Mellitus, Type 1 / Antibodies, Monoclonal Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Female / Humans / Male Language: En Journal: Diabet Med Journal subject: ENDOCRINOLOGIA Year: 2010 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom